Skip to content

Medical-device intelligence

MYI: System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies

FDA product code MYI: System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
MYI
FDA device name
System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies
Device class
2
Regulation number
866.1640
Medical specialty
Microbiology
Review panel
MI

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

10 clearance records and 0 recall records in the covered releases, across 7 source company names and 1 product codes. Dated history runs from Jul 9, 1999 to Oct 10, 2014.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

10 matching records
Device / recordCompany in FDA recordSourceSource date
MECA XPRESSFISHK140619 · MYIAdvandx, Inc.510(k)Oct 10, 2014FDA decision date
ALERE PBP2A SA/CONS CULTURE COLONY TESTK133851 · MYIAlere Scarborough, Inc.510(k)Sep 3, 2014FDA decision date
ALERE PBP2A TESTK121905 · MYIAlere Scarborough, Inc.510(k)Jul 26, 2012FDA decision date
BINAXNOW PBP2A TEST, MODEL 890-000K090301 · MYIBinax, Inc.510(k)Apr 14, 2010FDA decision date
CLEARVIEW EXACT PBP2A TEST, MODEL 891-000K091766 · MYIBinax, Inc.510(k)Feb 24, 2010FDA decision date
MASTALEX -MRSA, MODEL RST501K062864 · MYIMast Group , Ltd.510(k)Oct 18, 2006FDA decision date
OXOID PBP2 1 LATEX AGGLUTINATION TESTK011710 · MYIOxoid , Ltd.510(k)Apr 2, 2002FDA decision date
MRSA-SCREENK011400 · MYIDenka Seiken'S510(k)Mar 27, 2002FDA decision date
VELOGENE GENOMIC IDENTIFICATION ASSAY FOR MRSA WITH ONE-STEP DETECTIONK010858 · MYIId Biomedical Corp.510(k)May 24, 2001FDA decision date
VELOGENE RAPID MRSA IDENTIFICATION ASSAYK990640 · MYIId Biomedical Corp.510(k)Jul 9, 1999FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗